An update on the risk of transmission of Ebola virus (EBOV) via the food chain – Part 2

EFSA Journal

Volumn 13, Issue 3, 2015, Pages

[No Author Info available]

Author keywords

food; foodborne transmission; fruits; survival; vegetables; Za re Ebola virus; ZEBOV

Indexed keywords

EID: 85015554168     PISSN: None     EISSN: 18314732     Source Type: Journal    
DOI: 10.2903/j.efsa.2015.4042     Document Type: Article

References (43)

1. Bannister B, 2010. Viral haemorrhagic fevers imported into non-endemic countries: risk assessment and management. British Medical Bulletin, 95, 193–225.
2. Bausch DG, 2011. Ebola Virus as a Foodborne Pathogen? Cause for Consideration, but Not Panic. Journal of Infectious Diseases, 204, 179–181.
3. Bausch DG, Towner JS, Dowell SF, Kaducu F, Lukwiya M, Sanchez A, Nichol ST, Ksiazek TG and Rollin PE, 2007. Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. Journal of Infectious Diseases, 196, S142–S147.
4. CDC (Centers for Disease Control and Prevention), 2014. Interim Guidance for Managers and Workers Handling Untreated Sewage from Individuals with Ebola in the United States.
5. CODEX (Codex Alimentarius Commission), 2007. Working principles for risk analysis for food safety for application by governments. Available at: www.codexalimentarius.net/input/download/standards/10751/CXG_062e.pdf
6. Colebunders R and Borchert N, 2000. Ebola haemorrhagic fever – a review. Journal of Infection, 40, 16–20.
7. Dowell SF, Mukunu R, Ksiazek TG, Khan AS, Rollin PE, Peters CJ and Commission Lutte Epidemies K, 1999. Transmission of Ebola hemorrhagic fever: A study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. Journal of Infectious Diseases, 179, S87–S91.
8. ECDC (European Centre for Disease Prevention and Control), 2014. Outbreak of Ebola virus disease in west Africa. Seventh update, 17 October 2014. Available at: http://ec.europa.eu/health/preparedness_response/docs/ebola_riskassessment_en.pdf
9. ECDC (European Centre for Disease Prevention and Control), 2015. Medical evacuations and repatriations from EVD-affected countries. Last updated: 27 February 2015. Available at http://www.ecdc.europa.eu/en/healthtopics/ebola_marburg_fevers/Pages/medical-evacuations.aspx.
10. EFSA (European Food Safety Authority), 2014a. Risk related to household pets in contact with Ebola cases in humans. EFSA Journal 2014; 12 (12): 3930, 12 pp. doi:10.2903/j.efsa.2014.3930.
11. EFSA (European Food Safety Authority), 2014a. An update on the risk of transmission of Ebola virus (EBOV) via the food chain. EFSA Journal 2014; 12 (11): 3884, 25 pp. doi:10.2903/j.efsa.2014.3884
12. EFSA Panel on Biological Hazards (BIOHAZ), 2012. Scientific Opinion on the development of a risk ranking framework on biological hazards. EFSA Journal 2012; 10 (6): 2724, 88 pp. doi:10.2903/j.efsa.2012.2724
13. FAO (Food and Agriculture Organization of the United Nations), 2015. Addressing Zaire Ebola virus (EBV) outbreaks. Rapid Qualitative Exposure and Release Assessment. Rome.
14. Feldmann H and Geisbert TW, 2011. Ebola haemorrhagic fever. Lancet, 377, 849–862.
15. Gonzalez JP, Pourrut X and Leroy E, 2007. Ebolavirus and other Filoviruses. In: Wildlife and Emerging Zoonotic Diseases: The Biology, Circumstances and Consequences of Cross-Species Transmission. Eds Childs JE, Mackenzie JS and Richt JA, Springer-Verlag, Berlin, Germany, 363–387.
16. Jaax NK, Davis KJ, Geisbert TJ, Vogel P, Jaax GP, Topper M and Jahrling PB, 1996. Lethal experimental infection of rhesus monkeys with Ebola-Zaire (Mayinga) virus by the oral and conjunctival route of exposure. Archives of Pathology & Laboratory Medicine, 120, 140–155.
17. Johnson B, Ocheng D, Gichogo A, Okiro M, Libondo D, Tukei P, Ho M, Mugambi M, Timms G and French M, 1983. Antibodies against haemorrhagic fever viruses in Kenya populations. Transactions of the Royal Society of Tropical Medicine and Hygiene, 77, 731–733.
18. Kobinger GP, Leung A, Neufeld J, Richardson JS, Falzarano D, Smith G, Tierney K, Patel A and Weingartl HM, 2011. Replication, Pathogenicity, Shedding, and Transmission of Zaire ebolavirus in Pigs. Journal of Infectious Diseases, 204, 200–208.
19. Ksiazek TG, Rollin PE, Williams AJ, Bressler DS, Martin ML, Swanepoel R, Burt FJ, Leman PA, Khan AS, Rowe AK, Mukunu R, Sanchez A and Peters CJ, 1999. Clinical virology of Ebola hemorrhagic fever (EHF): Virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. Journal of Infectious Diseases, 179, S177–S187.
20. Leroy EM, Baize S, Volchkov VE, Fisher-Hoch SP, Georges-Courbot MC, Lansoud-Soukate J, Capron M, Debre P, McCormick JB and Georges AJ, 2000. Human asymptomatic Ebola infection and strong inflammatory response. Lancet, 355, 2210–2215.
21. Lytle CD and Sagripanti JL, 2005. Predicted inactivation of viruses of relevance to biodefense by solar radiation. Journal of Virology, 79, 14244–14252.
22. Mathiot CC, Fontenille D, Georges AJ and Coulanges P, 1989. Antibodies to haemorrhagic fever viruses in Madagascar populations. Transactions of the Royal Society of Tropical Medicine and Hygiene, 83, 407–409.
23. Mitchell SW and McCormick JB, 1984. Physicochemical inactivation of Lassa, Ebola, and Marburg viruses and effect on clinical laboratory analyses. Journal of Clinical Microbiology, 20, 486–489.
24. Nkoghe D, Kone ML, Yada A and Leroy E, 2011a. A limited outbreak of Ebola haemorrhagic fever in Etoumbi, Republic of Congo, 2005. Transactions of the Royal Society of Tropical Medicine and Hygiene, 105, 466–472.
25. Nkoghe D, Padilla C, Becquart P, Wauquier N, Moussavou G, Akue JP, Ollomo B, Pourrut X, Souris M, Kazanji M, Gonzalez J-P and Leroy E, 2011a. Risk Factors for Zaire ebolavirus-Specific IgG in Rural Gabonese Populations. Journal of Infectious Diseases, 204, S768–S775.
26. OIE (World Organization for Animal Health), 2014. Terrestrial animal health code. Volume I: general provisions. Ed.22. Paris, France. 384.
27. Olival KJ and Hayman DTS, 2014. Filoviruses in Bats: Current Knowledge and Future Directions. Viruses-Basel, 6, 1759–1788.
28. Paweska JT, Jansen van Vuren P, Masumu J, Leman PA, Grobbelaar AA, Birkhead M, Clift S, Swanepoel R and Kemp A, 2012. Virological and serological findings in Rousettus aegyptiacus experimentally inoculated with vero cells-adapted hogan strain of Marburg virus. Plos One, 7, e45479.
29. Petit P, Johnson B, Hermans J and Tukei P, 1996. Hemorrhagic fevers: few clues after 25 years. African journal of health sciences, 3, 141–148.
30. PHE (Public Health England), 2014. Ebola: information for sewage and water handlers. PHE publications gateway number: 2014520. 5.
31. Piercy TJ, Smither SJ, Steward JA, Eastaugh L and Lever MS, 2010. The survival of filoviruses in liquids, on solid substrates and in a dynamic aerosol. Journal of Applied Microbiology, 109, 1531–1539.
32. Plowright RK, Eby P, Hudson PJ, Smith IL, Westcott D, Bryden WL, Middleton D, Reid PA, McFarlane RA, Martin G, Tabor GM, Skerratt LF, Anderson DL, Crameri G, Quammen D, Jordan D, Freeman P, Wang L-F, Epstein JH, Marsh GA, Kung NY and McCallum H, 2015. Ecological dynamics of emerging bat virus spillover. Proceedings of the Royal Society B-Biological Sciences, 282.
33. Pourrut X, Kumulungui B, Wittmann T, Moussavou G, Delicat A, Yaba P, Nkoghe D, Gonzalez JP and Leroy EM, 2005. The natural history of Ebola virus in Africa. Microbes and Infection, 7, 1005–1014.
34. Prescott J, Bushmaker T, Fischer R, Miazgowicz K, Judson S and Munster V.J., 2015. Postmortem Stability of Ebola Virus. Emerging Infectious Disease journal, 21.
35. Rowe AK, Bertolli J, Khan AS, Mukunu R, Muyembe-Tamfum JJ, Bressler D, Williams AJ, Peters CJ, Rodriguez L, Feldmann H, Nichol ST, Rollin PE, Ksiazek TG and Commission Lutte Epidemies K, 1999. Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Journal of Infectious Diseases, 179, S28–S35.
36. Sagripanti J-L and Lytle CD, 2011. Sensitivity to ultraviolet radiation of Lassa, vaccinia, and Ebola viruses dried on surfaces. Archives of Virology, 156, 489–494.
37. Sagripanti J-L, Rom AM and Holland LE, 2010. Persistence in darkness of virulent alphaviruses, Ebola virus, and Lassa virus deposited on solid surfaces. Archives of Virology, 155, 2035–2039.
38. Swanepoel R, Leman PA, Burt FJ, Zachariades NA, Braack LEO, Ksiazek TG, Rollin PE, Zaki SR and Peters CJ, 1996. Experimental inoculation of plants and animals with Ebola virus. Emerging Infectious Diseases, 2, 321–325.
39. Towner JS, Rollin PE, Bausch DG, Sanchez A, Crary SM, Vincent M, Lee WF, Spiropoulou CF, Ksiazek TG, Lukwiya M, Kaducu F, Downing R and Nichol ST, 2004. Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. Journal of Virology, 78, 4330–4341.
40. WHO (World Health Organization), 2014a. Chronology of previous Ebola virus disease outbreaks. Available at http://www.who.int/mediacentre/factsheets/fs103/en/.
41. WHO (World Health Organization), 2014a. Ebola Virus Disease (EVD). Key questions and answers concerning water, sanitation and hygiene. World Health Organization, Geneva. Available at: http://www.who.int/water_sanitation_health/WASH_and_Ebola.pdf?ua=1
42. WHO (World Health Organization), 2014a. What we know about transmission of the Ebola virus among humans. Ebola situation assessment, Geneva, WHO. Available at: http://www.who.int/mediacentre/news/ebola/06-october-2014/en/.
43. WHO (World Health Organization), 2015. Ebola situation report. Available at: http://apps.who.int/ebola/en/current-situation